金井 雅史

最終更新日時: 2020/07/29 07:23:26

印刷する

氏名(漢字/フリガナ/アルファベット表記)
金井 雅史/カナイ マサシ/Kanai, Masashi
所属部署・職名(部局/所属/講座等/職名)
医学研究科/医学専攻内科学講座腫瘍薬物治療学/准教授
連絡先住所
種別 住所(日本語) 住所(英語)
職場 京都市左京区聖護院川原町54 Syogo-in Kawahara-cho 54, Sakyo-ku, Kyoto, Japan
連絡先電話番号
種別 番号
職場 075-751-4349
所属学会(国内)
学会名(日本語) 学会名(英語)
日本内科学会 Japanese Society of Internal Medicine
日本消化器病学会 Japanese Society of Gastroenterology
日本臨床腫瘍学会 Japanese Society of Medical Oncology
日本消化器内視鏡学会 Japanese Society of Gastroenterological Endoscopy
日本癌治療学会 Japanese Society of Clinical Oncology
日本膵臓学会 Japan Pancreas Society
所属学会(海外)
学会名(英語) 国名
American Society of Clinical Oncology USA
取得学位
学位名(日本語) 学位名(英語) 大学(日本語) 大学(英語) 取得区分
博士(医学) 京都大学
出身大学院・研究科等
大学名(日本語) 大学名(英語) 研究科名(日本語) 研究科名(英語) 専攻名(日本語) 専攻名(英語) 修了区分
京都大学 大学院医学研究科博士課程内科系専攻 研究指導認定退学
京都大学 大学院医学研究科博士課程内科系専攻 修了
出身学校・専攻等
大学名(日本語) 大学名(英語) 学部名(日本語) 学部名(英語) 学科名(日本語) 学科名(英語) 卒業区分
京都大学 医学部医学科 卒業
出身高等学校
高等学校名 ふりがな
洛南高校 らくなん
職歴
期間 組織名(日本語) 組織名(英語) 職名(日本語) 職名(英語)
1994/04/01〜1995/05/31 京都大学医学部附属病院 Kyoto University Hospital 研修医 Medical Residency
1995/06/01〜1997/03/31 関西電力病院 Kansai Denryoku Hospital 研修医 Medical Residency
2001/06/01〜2003/12/31 京都桂病院 Kyoto Katsura Hospital 副医長 Medial staff
2004/01/01〜2006/03/31 MDアンダーソンがんセンター MD Anderson Cancer Center ポストドクトラルフェロー Postdoctoral fellow
2006/04/01〜2010/03/31 京都大学医学部附属病院 探索医療センター 開発部 Translational Research Center, Kyoto University Hospital 特定助教 Assistant professor
2011/04/01〜2015/03/31 京都大学大学院医学研究科 臨床腫瘍薬理学講座 Department of Clinical Oncology and Pharmacogenomics, Graduate School of Medicine, Kyoto University 特定講師 Senior lecturer
2015/04/01〜2020/03/31 京都大学大学院医学研究科  臨床腫瘍薬理学・緩和医療学講座 Department of Clinical Oncology, Pharmacogenomics, and Palliative Medicine 特定准教授 Associate Professor
2020/04/01〜 京都大学大学院医学研究科  腫瘍薬物治療学講座 准教授 Associate Professor
researchmap URL
https://researchmap.jp/7000008596
研究テーマ
(日本語)
1.がんゲノム医療 2. 胆膵化学療法 3.新規抗がん薬開発
(英語)
1. Cancer precision medicine 2. Chemotherapy for patients with hepatobiliary and pancreatic cancer 3. Development of new anti-cancer drugs
研究分野(キーワード)
キーワード(日本語) キーワード(英語)
ゲノム医療 genomic medicine
膵癌 pancreatic cancer
胆道癌 biliary tract cancer
個別化医療 precision medicine
論文
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 書誌情報等 書誌情報等(日本語) 書誌情報等(英語) 出版年月 査読の有無 記述言語 掲載種別 公開
Hatano E, Kanai M, Nagano H, Ioka T Hatano E, Kanai M, Nagano H, Ioka T Hatano E, Kanai M, Nagano H, Ioka T [Clinical study of new chemotherapy regimen for biliary tract cancer]. [Clinical study of new chemotherapy regimen for biliary tract cancer]. [Clinical study of new chemotherapy regimen for biliary tract cancer]. Nihon rinsho. Japanese journal of clinical medicine, 73 Suppl 3, 805-808 Nihon rinsho. Japanese journal of clinical medicine, 73 Suppl 3, 805-808 Nihon rinsho. Japanese journal of clinical medicine, 73 Suppl 3, 805-808 2015/03 公開
Masashi Kanai, Etsuro Hatano, Shogo Kobayashi, Yutaka Fujiwara, Shigeru Marubashi, Atsushi Miyamoto, Hisanori Shiomi, Shoji Kubo, Shinichi Ikuta, Hiroaki Yanagimoto, Hiroaki Terajima, Hisashi Ikoma, Daisuke Sakai, Yuzo Kodama, Satoru Seo, Satoshi Morita, Tetsuo Ajiki, Hiroaki Nagano, Tatsuya Ioka Masashi Kanai, Etsuro Hatano, Shogo Kobayashi, Yutaka Fujiwara, Shigeru Marubashi, Atsushi Miyamoto, Hisanori Shiomi, Shoji Kubo, Shinichi Ikuta, Hiroaki Yanagimoto, Hiroaki Terajima, Hisashi Ikoma, Daisuke Sakai, Yuzo Kodama, Satoru Seo, Satoshi Morita, Tetsuo Ajiki, Hiroaki Nagano, Tatsuya Ioka Masashi Kanai, Etsuro Hatano, Shogo Kobayashi, Yutaka Fujiwara, Shigeru Marubashi, Atsushi Miyamoto, Hisanori Shiomi, Shoji Kubo, Shinichi Ikuta, Hiroaki Yanagimoto, Hiroaki Terajima, Hisashi Ikoma, Daisuke Sakai, Yuzo Kodama, Satoru Seo, Satoshi Morita, Tetsuo Ajiki, Hiroaki Nagano, Tatsuya Ioka A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002) A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002) A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002) CANCER CHEMOTHERAPY AND PHARMACOLOGY, 75, 2, 293-300 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 75, 2, 293-300 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 75, 2, 293-300 2015/02 英語 研究論文(学術雑誌) 公開
Shogo Kobayashi, Hiroaki Nagano, Daisuke Sakai, Hidetoshi Eguchi, Etsuro Hatano, Masashi Kanai, Satoru Seo, Kojiro Taura, Yutaka Fujiwara, Tetsuo Ajiki, Shigekazu Takemura, Shoji Kubo, Hiroaki Yanagimoto, Hideyoshi Toyokawa, Akihito Tsuji, Hiroaki Terajima, Satoshi Morita, Tatsuya Ioka Shogo Kobayashi, Hiroaki Nagano, Daisuke Sakai, Hidetoshi Eguchi, Etsuro Hatano, Masashi Kanai, Satoru Seo, Kojiro Taura, Yutaka Fujiwara, Tetsuo Ajiki, Shigekazu Takemura, Shoji Kubo, Hiroaki Yanagimoto, Hideyoshi Toyokawa, Akihito Tsuji, Hiroaki Terajima, Satoshi Morita, Tatsuya Ioka Shogo Kobayashi, Hiroaki Nagano, Daisuke Sakai, Hidetoshi Eguchi, Etsuro Hatano, Masashi Kanai, Satoru Seo, Kojiro Taura, Yutaka Fujiwara, Tetsuo Ajiki, Shigekazu Takemura, Shoji Kubo, Hiroaki Yanagimoto, Hideyoshi Toyokawa, Akihito Tsuji, Hiroaki Terajima, Satoshi Morita, Tatsuya Ioka Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study. Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study. Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study. Cancer chemotherapy and pharmacology, 74, 4, 699-709 Cancer chemotherapy and pharmacology, 74, 4, 699-709 Cancer chemotherapy and pharmacology, 74, 4, 699-709 2014/10 英語 公開
Masashi Kanai Masashi Kanai Masashi Kanai Therapeutic applications of curcumin for patients with pancreatic cancer Therapeutic applications of curcumin for patients with pancreatic cancer Therapeutic applications of curcumin for patients with pancreatic cancer WORLD JOURNAL OF GASTROENTEROLOGY, 20, 28, 9384-9391 WORLD JOURNAL OF GASTROENTEROLOGY, 20, 28, 9384-9391 WORLD JOURNAL OF GASTROENTEROLOGY, 20, 28, 9384-9391 2014/07 英語 研究論文(学術雑誌) 公開
Masanori Toyoda, Tetsuo Ajiki, Yutaka Fujiwara, Hiroaki Nagano, Shogo Kobayashi, Daisuke Sakai, Etsuro Hatano, Masashi Kanai, Shoji Nakamori, Atsushi Miyamoto, Akihito Tsuji, Satoshi Kaihara, Hisashi Ikoma, Shigekazu Takemura, Hideyoshi Toyokawa, Hiroaki Terajima, Satoshi Morita, Tatsuya Ioka Masanori Toyoda, Tetsuo Ajiki, Yutaka Fujiwara, Hiroaki Nagano, Shogo Kobayashi, Daisuke Sakai, Etsuro Hatano, Masashi Kanai, Shoji Nakamori, Atsushi Miyamoto, Akihito Tsuji, Satoshi Kaihara, Hisashi Ikoma, Shigekazu Takemura, Hideyoshi Toyokawa, Hiroaki Terajima, Satoshi Morita, Tatsuya Ioka Masanori Toyoda, Tetsuo Ajiki, Yutaka Fujiwara, Hiroaki Nagano, Shogo Kobayashi, Daisuke Sakai, Etsuro Hatano, Masashi Kanai, Shoji Nakamori, Atsushi Miyamoto, Akihito Tsuji, Satoshi Kaihara, Hisashi Ikoma, Shigekazu Takemura, Hideyoshi Toyokawa, Hiroaki Terajima, Satoshi Morita, Tatsuya Ioka Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004) Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004) Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004) CANCER CHEMOTHERAPY AND PHARMACOLOGY, 73, 6, 1295-1301 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 73, 6, 1295-1301 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 73, 6, 1295-1301 2014/06 英語 研究論文(学術雑誌) 公開
Kenya Yamanaka, Etsuro Hatano, Masashi Kanai, Shiro Tanaka, Keiichi Yamamoto, Masato Narita, Hiromitsu Nagata, Takamichi Ishii, Takahumi Machimoto, Kojiro Taura, Shinji Uemoto Kenya Yamanaka, Etsuro Hatano, Masashi Kanai, Shiro Tanaka, Keiichi Yamamoto, Masato Narita, Hiromitsu Nagata, Takamichi Ishii, Takahumi Machimoto, Kojiro Taura, Shinji Uemoto Kenya Yamanaka, Etsuro Hatano, Masashi Kanai, Shiro Tanaka, Keiichi Yamamoto, Masato Narita, Hiromitsu Nagata, Takamichi Ishii, Takahumi Machimoto, Kojiro Taura, Shinji Uemoto A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 3, 485-489 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 3, 485-489 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 3, 485-489 2014/06 英語 研究論文(学術雑誌) 公開
Peng Xue, Masashi Kanai, Yukiko Mori, Takafumi Nishimura, Norimitsu Uza, Yuzo Kodama, Yoshiya Kawaguchi, Kyoichi Takaori, Shigemi Matsumoto, Shinji Uemoto, Tsutomu Chiba Peng Xue, Masashi Kanai, Yukiko Mori, Takafumi Nishimura, Norimitsu Uza, Yuzo Kodama, Yoshiya Kawaguchi, Kyoichi Takaori, Shigemi Matsumoto, Shinji Uemoto, Tsutomu Chiba Peng Xue, Masashi Kanai, Yukiko Mori, Takafumi Nishimura, Norimitsu Uza, Yuzo Kodama, Yoshiya Kawaguchi, Kyoichi Takaori, Shigemi Matsumoto, Shinji Uemoto, Tsutomu Chiba Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients CANCER MEDICINE, 3, 2, 406-415 CANCER MEDICINE, 3, 2, 406-415 CANCER MEDICINE, 3, 2, 406-415 2014/04 英語 研究論文(学術雑誌) 公開
Peng Xue, Masashi Kanai, Yukiko Mori, Takafumi Nishimura, Norimitsu Uza, Yuzo Kodama, Yoshiya Kawaguchi, Kyoichi Takaori, Shigemi Matsumoto, Shinji Uemoto, Tsutomu Chiba Peng Xue, Masashi Kanai, Yukiko Mori, Takafumi Nishimura, Norimitsu Uza, Yuzo Kodama, Yoshiya Kawaguchi, Kyoichi Takaori, Shigemi Matsumoto, Shinji Uemoto, Tsutomu Chiba Peng Xue, Masashi Kanai, Yukiko Mori, Takafumi Nishimura, Norimitsu Uza, Yuzo Kodama, Yoshiya Kawaguchi, Kyoichi Takaori, Shigemi Matsumoto, Shinji Uemoto, Tsutomu Chiba Comparative Outcomes Between Initially Unresectable and Recurrent Cases of Advanced Pancreatic Cancer Following Palliative Chemotherapy Comparative Outcomes Between Initially Unresectable and Recurrent Cases of Advanced Pancreatic Cancer Following Palliative Chemotherapy Comparative Outcomes Between Initially Unresectable and Recurrent Cases of Advanced Pancreatic Cancer Following Palliative Chemotherapy PANCREAS, 43, 3, 411-416 PANCREAS, 43, 3, 411-416 PANCREAS, 43, 3, 411-416 2014/04 英語 研究論文(学術雑誌) 公開
Kenji Ikezawa, Masashi Kanai, Tetsuo Ajiki, Tadashi Tsukamoto, Hideyoshi Toyokawa, Hiroaki Terajima, Hiroaki Furuyama, Hiroaki Nagano, Iwao Ikai, Nobukazu Kuroda, Masaaki Awane, Toshiya Ochiai, Shigekazu Takemura, Atsushi Miyamoto, Makoto Kume, Masao Ogawa, Yutaka Takeda, Kaoru Taira, Tatsuya Ioka Kenji Ikezawa, Masashi Kanai, Tetsuo Ajiki, Tadashi Tsukamoto, Hideyoshi Toyokawa, Hiroaki Terajima, Hiroaki Furuyama, Hiroaki Nagano, Iwao Ikai, Nobukazu Kuroda, Masaaki Awane, Toshiya Ochiai, Shigekazu Takemura, Atsushi Miyamoto, Makoto Kume, Masao Ogawa, Yutaka Takeda, Kaoru Taira, Tatsuya Ioka Kenji Ikezawa, Masashi Kanai, Tetsuo Ajiki, Tadashi Tsukamoto, Hideyoshi Toyokawa, Hiroaki Terajima, Hiroaki Furuyama, Hiroaki Nagano, Iwao Ikai, Nobukazu Kuroda, Masaaki Awane, Toshiya Ochiai, Shigekazu Takemura, Atsushi Miyamoto, Makoto Kume, Masao Ogawa, Yutaka Takeda, Kaoru Taira, Tatsuya Ioka Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 21, 2, 98-104 JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 21, 2, 98-104 JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 21, 2, 98-104 2014/02 英語 研究論文(学術雑誌) 公開
Tadayuki Kou, Masashi Kanai, Kenji Ikezawa, Tetsuo Ajiki, Tadashi Tsukamoto, Hideyoshi Toyokawa, Shujiro Yazumi, Hiroaki Terajima, Hiroaki Furuyama, Hiroaki Nagano, Iwao Ikai, Nobukazu Kuroda, Masaaki Awane, Toshiya Ochiai, Shigekazu Takemura, Atsushi Miyamoto, Makoto Kume, Masao Ogawa, Yutaka Takeda, Kaoru Taira, Tatsuya Ioka Tadayuki Kou, Masashi Kanai, Kenji Ikezawa, Tetsuo Ajiki, Tadashi Tsukamoto, Hideyoshi Toyokawa, Shujiro Yazumi, Hiroaki Terajima, Hiroaki Furuyama, Hiroaki Nagano, Iwao Ikai, Nobukazu Kuroda, Masaaki Awane, Toshiya Ochiai, Shigekazu Takemura, Atsushi Miyamoto, Makoto Kume, Masao Ogawa, Yutaka Takeda, Kaoru Taira, Tatsuya Ioka Tadayuki Kou, Masashi Kanai, Kenji Ikezawa, Tetsuo Ajiki, Tadashi Tsukamoto, Hideyoshi Toyokawa, Shujiro Yazumi, Hiroaki Terajima, Hiroaki Furuyama, Hiroaki Nagano, Iwao Ikai, Nobukazu Kuroda, Masaaki Awane, Toshiya Ochiai, Shigekazu Takemura, Atsushi Miyamoto, Makoto Kume, Masao Ogawa, Yutaka Takeda, Kaoru Taira, Tatsuya Ioka Comparative outcomes of elderly and non-elderly patients receiving first-line palliative chemotherapy for advanced biliary tract cancer Comparative outcomes of elderly and non-elderly patients receiving first-line palliative chemotherapy for advanced biliary tract cancer Comparative outcomes of elderly and non-elderly patients receiving first-line palliative chemotherapy for advanced biliary tract cancer JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 29, 2, 403-408 JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 29, 2, 403-408 JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 29, 2, 403-408 2014/02 英語 研究論文(学術雑誌) 公開
Kanai M, Kawaguchi T, Matsumoto S, Matsuda F Kanai M, Kawaguchi T, Matsumoto S, Matsuda F M. Kanai, T. Kawaguchi, S. Matsumoto, F. Matsuda [Development of pharmacogenomics--guided tailored therapy for colorectal cancer]. [Development of pharmacogenomics--guided tailored therapy for colorectal cancer]. [Development of pharmacogenomics--guided tailored therapy for colorectal cancer]. Nihon rinsho. Japanese journal of clinical medicine, 72, 1, 23-28 Nihon rinsho. Japanese journal of clinical medicine, 72, 1, 23-28 Nihon rinsho. Japanese journal of clinical medicine, 72, 1, 23-28 2014/01 英語 公開
Nagai H, Kitano T, Nishimura T, Yasuda H, Nakata K, Takashima S, Kanai M, Matsumoto S, Mori Y, Kakudo Y, Sato H, Yamaguchi T, Kameno K, Kim YH, Mishima M, Yanagihara K Nagai H, Kitano T, Nishimura T, Yasuda H, Nakata K, Takashima S, Kanai M, Matsumoto S, Mori Y, Kakudo Y, Sato H, Yamaguchi T, Kameno K, Kim YH, Mishima M, Yanagihara K H. Nagai, T. Kitano, T. Nishimura, H. Yasuda, K. Nakata, S. Takashima, M. Kanai, S. Matsumoto, Y. Mori, Y. Kakudo, H. Sato, T. Yamaguchi, K. Kameno, Y.H. Kim, M. Mishima, K. Yanagihara Use of glucose solution for the alleviation of gemcitabine-induced vascular pain: a double-blind randomized crossover study. Use of glucose solution for the alleviation of gemcitabine-induced vascular pain: a double-blind randomized crossover study. Use of glucose solution for the alleviation of gemcitabine-induced vascular pain: A double-blind randomized crossover study Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 21, 12, 3271-3278 Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 21, 12, 3271-3278 Supportive Care in Cancer, 21, 12, 3271-3278 2013/12 英語 公開
Masashi Kanai, Yoshihiko Otsuka, Kazunori Otsuka, Maremi Sato, Takafumi Nishimura, Yukiko Mori, Michiya Kawaguchi, Etsuro Hatano, Yuzo Kodama, Shigemi Matsumoto, Yoshiki Murakami, Atsushi Imaizumi, Tsutomu Chiba, Jun Nishihira, Hiroyuki Shibata Masashi Kanai, Yoshihiko Otsuka, Kazunori Otsuka, Maremi Sato, Takafumi Nishimura, Yukiko Mori, Michiya Kawaguchi, Etsuro Hatano, Yuzo Kodama, Shigemi Matsumoto, Yoshiki Murakami, Atsushi Imaizumi, Tsutomu Chiba, Jun Nishihira, Hiroyuki Shibata Masashi Kanai, Yoshihiko Otsuka, Kazunori Otsuka, Maremi Sato, Takafumi Nishimura, Yukiko Mori, Michiya Kawaguchi, Etsuro Hatano, Yuzo Kodama, Shigemi Matsumoto, Yoshiki Murakami, Atsushi Imaizumi, Tsutomu Chiba, Jun Nishihira, Hiroyuki Shibata A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin(A (R))) in cancer patients A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin(A (R))) in cancer patients A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin(A (R))) in cancer patients CANCER CHEMOTHERAPY AND PHARMACOLOGY, 71, 6, 1521-1530 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 71, 6, 1521-1530 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 71, 6, 1521-1530 2013/06 英語 研究論文(学術雑誌) 公開
Masashi Kanai, Etsuro Hatano, Syogo Kobayashi, Yutaka Fujiwara, Daisuke Sakai, Yuzo Kodama, Tetsuo Ajiki, Hiroaki Nagano, Tatsuya Ioka Masashi Kanai, Etsuro Hatano, Syogo Kobayashi, Yutaka Fujiwara, Daisuke Sakai, Yuzo Kodama, Tetsuo Ajiki, Hiroaki Nagano, Tatsuya Ioka Masashi Kanai, Etsuro Hatano, Syogo Kobayashi, Yutaka Fujiwara, Daisuke Sakai, Yuzo Kodama, Tetsuo Ajiki, Hiroaki Nagano, Tatsuya Ioka Phase I trial of oral S-1 combined with gemcitabine and cisplatin for advanced biliary tract cancer (KHBO1002) Phase I trial of oral S-1 combined with gemcitabine and cisplatin for advanced biliary tract cancer (KHBO1002) Phase I trial of oral S-1 combined with gemcitabine and cisplatin for advanced biliary tract cancer (KHBO1002) CANCER CHEMOTHERAPY AND PHARMACOLOGY, 69, 5, 1181-1188 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 69, 5, 1181-1188 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 69, 5, 1181-1188 2012/05 英語 研究論文(学術雑誌) 公開
M. Kanai M. Kanai M. Kanai The potential role of curcumin as a chemotherapeutic drug The potential role of curcumin as a chemotherapeutic drug The potential role of curcumin as a chemotherapeutic drug Curcumin: Biosynthesis, Medicinal Uses and Health Benefits, 207-222 Curcumin: Biosynthesis, Medicinal Uses and Health Benefits, 207-222 Curcumin: Biosynthesis, Medicinal Uses and Health Benefits, 207-222 2012 英語 公開
M. Kanai, S. Matsumoto, Y. Otsuka, M. Fukuda, A. Imaizumi M. Kanai, S. Matsumoto, Y. Otsuka, M. Fukuda, A. Imaizumi M. Kanai, S. Matsumoto, Y. Otsuka, M. Fukuda, A. Imaizumi In response In response In response Cancer Chemotherapy and Pharmacology, 70, 3, 489- Cancer Chemotherapy and Pharmacology, 70, 3, 489- Cancer Chemotherapy and Pharmacology, 70, 3, 489- 2012 英語 公開
Masashi Kanai, Atsushi Imaizumi, Yoshihiko Otsuka, Hiroki Sasaki, Momo Hashiguchi, Kazu Tsujiko, Shigemi Matsumoto, Hiroshi Ishiguro, Tsutomu Chiba Masashi Kanai, Atsushi Imaizumi, Yoshihiko Otsuka, Hiroki Sasaki, Momo Hashiguchi, Kazu Tsujiko, Shigemi Matsumoto, Hiroshi Ishiguro, Tsutomu Chiba Masashi Kanai, Atsushi Imaizumi, Yoshihiko Otsuka, Hiroki Sasaki, Momo Hashiguchi, Kazu Tsujiko, Shigemi Matsumoto, Hiroshi Ishiguro, Tsutomu Chiba Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers CANCER CHEMOTHERAPY AND PHARMACOLOGY, 69, 1, 65-70 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 69, 1, 65-70 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 69, 1, 65-70 2012/01 英語 研究論文(学術雑誌) 公開
M. Kanai, H. Ishiguro, Y. Mori, T. Kitano, T. Nishimura, S. Matsumoto, K. Yanagihara, T. Chiba, M. Toi M. Kanai, H. Ishiguro, Y. Mori, T. Kitano, T. Nishimura, S. Matsumoto, K. Yanagihara, T. Chiba, M. Toi M. Kanai, H. Ishiguro, Y. Mori, T. Kitano, T. Nishimura, S. Matsumoto, K. Yanagihara, T. Chiba, M. Toi Temporary blood pressure drop after bevacizumab administration is associated with clinical course of advanced colorectal cancer Temporary blood pressure drop after bevacizumab administration is associated with clinical course of advanced colorectal cancer Temporary blood pressure drop after bevacizumab administration is associated with clinical course of advanced colorectal cancer BRITISH JOURNAL OF CANCER, 105, 11, 1693-1696 BRITISH JOURNAL OF CANCER, 105, 11, 1693-1696 BRITISH JOURNAL OF CANCER, 105, 11, 1693-1696 2011/11 英語 研究論文(学術雑誌) 公開
Masashi Kanai, Kenichi Yoshimura, Masanori Asada, Atsushi Imaizumi, Chihiro Suzuki, Shigemi Matsumoto, Takafumi Nishimura, Yukiko Mori, Toshihiko Masui, Yoshiya Kawaguchi, Kazuhiro Yanagihara, Shujiro Yazumi, Tsutomu Chiba, Sushovan Guha, Bharat B. Aggarwal Masashi Kanai, Kenichi Yoshimura, Masanori Asada, Atsushi Imaizumi, Chihiro Suzuki, Shigemi Matsumoto, Takafumi Nishimura, Yukiko Mori, Toshihiko Masui, Yoshiya Kawaguchi, Kazuhiro Yanagihara, Shujiro Yazumi, Tsutomu Chiba, Sushovan Guha, Bharat B. Aggarwal Masashi Kanai, Kenichi Yoshimura, Masanori Asada, Atsushi Imaizumi, Chihiro Suzuki, Shigemi Matsumoto, Takafumi Nishimura, Yukiko Mori, Toshihiko Masui, Yoshiya Kawaguchi, Kazuhiro Yanagihara, Shujiro Yazumi, Tsutomu Chiba, Sushovan Guha, Bharat B. Aggarwal A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer CANCER CHEMOTHERAPY AND PHARMACOLOGY, 68, 1, 157-164 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 68, 1, 157-164 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 68, 1, 157-164 2011/07 英語 研究論文(学術雑誌) 公開
Masashi Kanai, Kenichi Yoshimura, Takehiko Tsumura, Masanori Asada, Chihiro Suzuki, Miyuki Niimi, Shigemi Matsumoto, Takafumi Nishimura, Takashi Nitta, Kentaro Yasuchika, Kojiro Taura, Yukiko Mori, Akihiko Hamada, Naoya Inoue, Shinsuke Tada, Kazuhiro Yanagihara, Shujiro Yazumi, Yukio Osaki, Tsutomu Chiba, Iwao Ikai, Masanori Fukushima, Shinji Uemoto, Etsuro Hatano Masashi Kanai, Kenichi Yoshimura, Takehiko Tsumura, Masanori Asada, Chihiro Suzuki, Miyuki Niimi, Shigemi Matsumoto, Takafumi Nishimura, Takashi Nitta, Kentaro Yasuchika, Kojiro Taura, Yukiko Mori, Akihiko Hamada, Naoya Inoue, Shinsuke Tada, Kazuhiro Yanagihara, Shujiro Yazumi, Yukio Osaki, Tsutomu Chiba, Iwao Ikai, Masanori Fukushima, Shinji Uemoto, Etsuro Hatano Masashi Kanai, Kenichi Yoshimura, Takehiko Tsumura, Masanori Asada, Chihiro Suzuki, Miyuki Niimi, Shigemi Matsumoto, Takafumi Nishimura, Takashi Nitta, Kentaro Yasuchika, Kojiro Taura, Yukiko Mori, Akihiko Hamada, Naoya Inoue, Shinsuke Tada, Kazuhiro Yanagihara, Shujiro Yazumi, Yukio Osaki, Tsutomu Chiba, Iwao Ikai, Masanori Fukushima, Shinji Uemoto, Etsuro Hatano A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer CANCER CHEMOTHERAPY AND PHARMACOLOGY, 67, 6, 1429-1434 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 67, 6, 1429-1434 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 67, 6, 1429-1434 2011/06 英語 研究論文(学術雑誌) 公開
Masashi Kanai, Kenichi Yoshimura, Takehiko Tsumura, Masanori Asada, Chihiro Suzuki, Miyuki Niimi, Shigemi Matsumoto, Takafumi Nishimura, Takashi Nitta, Kentaro Yasuchika, Kojiro Taura, Yukiko Mori, Akihiko Hamada, Naoya Inoue, Shinsuke Tada, Kazuhiro Yanagihara, Shujiro Yazumi, Yukio Osaki, Tsutomu Chiba, Iwao Ikai, Masanori Fukushima, Shinji Uemoto, Etsuro Hatano Masashi Kanai, Kenichi Yoshimura, Takehiko Tsumura, Masanori Asada, Chihiro Suzuki, Miyuki Niimi, Shigemi Matsumoto, Takafumi Nishimura, Takashi Nitta, Kentaro Yasuchika, Kojiro Taura, Yukiko Mori, Akihiko Hamada, Naoya Inoue, Shinsuke Tada, Kazuhiro Yanagihara, Shujiro Yazumi, Yukio Osaki, Tsutomu Chiba, Iwao Ikai, Masanori Fukushima, Shinji Uemoto, Etsuro Hatano Masashi Kanai, Kenichi Yoshimura, Takehiko Tsumura, Masanori Asada, Chihiro Suzuki, Miyuki Niimi, Shigemi Matsumoto, Takafumi Nishimura, Takashi Nitta, Kentaro Yasuchika, Kojiro Taura, Yukiko Mori, Akihiko Hamada, Naoya Inoue, Shinsuke Tada, Kazuhiro Yanagihara, Shujiro Yazumi, Yukio Osaki, Tsutomu Chiba, Iwao Ikai, Masanori Fukushima, Shinji Uemoto, Etsuro Hatano A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer CANCER CHEMOTHERAPY AND PHARMACOLOGY, 67, 6, 1429-1434 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 67, 6, 1429-1434 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 67, 6, 1429-1434 2011/06 英語 研究論文(学術雑誌) 公開
C. Zaima, M. Kanai, S. Ishikawa, Y. Kawaguchi, T. Masui, Y. Mori, T. Nishimura, S. Matsumoto, K. Yanagihara, T. Chiba, T. Mimori C. Zaima, M. Kanai, S. Ishikawa, Y. Kawaguchi, T. Masui, Y. Mori, T. Nishimura, S. Matsumoto, K. Yanagihara, T. Chiba, T. Mimori C. Zaima, M. Kanai, S. Ishikawa, Y. Kawaguchi, T. Masui, Y. Mori, T. Nishimura, S. Matsumoto, K. Yanagihara, T. Chiba, T. Mimori A Case of Progressive Digital Ischemia after Early Withdrawal of Gemcitabine and S-1 in a Patient with Systemic Sclerosis A Case of Progressive Digital Ischemia after Early Withdrawal of Gemcitabine and S-1 in a Patient with Systemic Sclerosis A Case of Progressive Digital Ischemia after Early Withdrawal of Gemcitabine and S-1 in a Patient with Systemic Sclerosis JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 41, 6, 803-806 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 41, 6, 803-806 JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 41, 6, 803-806 2011/06 英語 研究論文(学術雑誌) 公開
Kanai M Kanai M Kanai M Dose-escalation and pharmacokinetic study of nanoparticlecurcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers Dose-escalation and pharmacokinetic study of nanoparticlecurcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers Dose-escalation and pharmacokinetic study of nanoparticlecurcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers Cancer Chemother Pharmacol. 2011 May 21 Cancer Chemother Pharmacol. 2011 May 21 Cancer Chemother Pharmacol. 2011 May 21 2011 英語 公開
Wei D, Wang L, Kanai M Wei D, Wang L, Kanai M Daoyan Wei, Liwei Wang, Masashi Kanai, Zhiliang Jia, Xiangdong Le, Qiang Li, Huamin Wang, Keping Xie KLF4α up-regulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer. KLF4α up-regulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer. KLF4 alpha Up-regulation Promotes Cell Cycle Progression and Reduces Survival Time of Patients With Pancreatic Cancer Gastroenterology. 139(6):2135-45.2010, 139, 6, 2135-2145 Gastroenterology. 139(6):2135-45.2010, 139, 6, 2135-2145 GASTROENTEROLOGY, 139, 6, 2135-2145 2010/12 英語 研究論文(学術雑誌) 公開
Kazuhiro Yanagihara, Kenichi Yoshimura, Miyuki Niimi, Hiroyasu Yasuda, Takahiko Sasaki, Takafumi Nishimura, Hiroshi Ishiguro, Shigemi Matsumoto, Toshiyuki Kitano, Masashi Kanai, Akiko Misawa, Harue Tada, Satoshi Teramukai, Tadashi Mio, Masanori Fukushima Kazuhiro Yanagihara, Kenichi Yoshimura, Miyuki Niimi, Hiroyasu Yasuda, Takahiko Sasaki, Takafumi Nishimura, Hiroshi Ishiguro, Shigemi Matsumoto, Toshiyuki Kitano, Masashi Kanai, Akiko Misawa, Harue Tada, Satoshi Teramukai, Tadashi Mio, Masanori Fukushima Kazuhiro Yanagihara, Kenichi Yoshimura, Miyuki Niimi, Hiroyasu Yasuda, Takahiko Sasaki, Takafumi Nishimura, Hiroshi Ishiguro, Shigemi Matsumoto, Toshiyuki Kitano, Masashi Kanai, Akiko Misawa, Harue Tada, Satoshi Teramukai, Tadashi Mio, Masanori Fukushima Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer CANCER CHEMOTHERAPY AND PHARMACOLOGY, 66, 5, 913-918 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 66, 5, 913-918 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 66, 5, 913-918 2010/10 英語 研究論文(学術雑誌) 公開
Masashi Kanai, Akira Yoshioka, Shiro Tanaka, Satoshi Nagayama, Shigemi Matsumoto, Takafumi Nishimura, Miyuki Niimi, Satoshi Teramukai, Ryo Takahashi, Yukiko Mori, Toshiyuki Kitano, Hiroshi Ishiguroa, Kazuhiro Yanagihara, Tsutomu Chiba, Masanori Fukushima, Fumihiko Matsuda Masashi Kanai, Akira Yoshioka, Shiro Tanaka, Satoshi Nagayama, Shigemi Matsumoto, Takafumi Nishimura, Miyuki Niimi, Satoshi Teramukai, Ryo Takahashi, Yukiko Mori, Toshiyuki Kitano, Hiroshi Ishiguroa, Kazuhiro Yanagihara, Tsutomu Chiba, Masanori Fukushima, Fumihiko Matsuda Masashi Kanai, Akira Yoshioka, Shiro Tanaka, Satoshi Nagayama, Shigemi Matsumoto, Takafumi Nishimura, Miyuki Niimi, Satoshi Teramukai, Ryo Takahashi, Yukiko Mori, Toshiyuki Kitano, Hiroshi Ishiguroa, Kazuhiro Yanagihara, Tsutomu Chiba, Masanori Fukushima, Fumihiko Matsuda Associations between glutathione S-transferase pi Ile(105)Val and glyoxylate aminotransferase Pro(11)Leu and Ile(340)Met polymorphisms and early-onset oxaliplatin-induced neuropathy Associations between glutathione S-transferase pi Ile(105)Val and glyoxylate aminotransferase Pro(11)Leu and Ile(340)Met polymorphisms and early-onset oxaliplatin-induced neuropathy Associations between glutathione S-transferase pi Ile(105)Val and glyoxylate aminotransferase Pro(11)Leu and Ile(340)Met polymorphisms and early-onset oxaliplatin-induced neuropathy CANCER EPIDEMIOLOGY, 34, 2, 189-193 CANCER EPIDEMIOLOGY, 34, 2, 189-193 CANCER EPIDEMIOLOGY, 34, 2, 189-193 2010/04 英語 研究論文(学術雑誌) 公開
M. Kanai, S. Matsumoto, T. Nishimura, Y. Matsumura, E. Hatano, A. Mori, T. Masui, Y. Kawaguchi, E. Nakamura, S. Tada, T. Kitano, H. Ishiguro, K. Yanagihara, T. Chiba M. Kanai, S. Matsumoto, T. Nishimura, Y. Matsumura, E. Hatano, A. Mori, T. Masui, Y. Kawaguchi, E. Nakamura, S. Tada, T. Kitano, H. Ishiguro, K. Yanagihara, T. Chiba M. Kanai, S. Matsumoto, T. Nishimura, Y. Matsumura, E. Hatano, A. Mori, T. Masui, Y. Kawaguchi, E. Nakamura, S. Tada, T. Kitano, H. Ishiguro, K. Yanagihara, T. Chiba Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy ANNALS OF ONCOLOGY, 21, 1, 189-190 ANNALS OF ONCOLOGY, 21, 1, 189-190 ANNALS OF ONCOLOGY, 21, 1, 189-190 2010/01 英語 公開
Yukiko Mori, Takafumi Nishimura, Toshiyuki Kitano, Ken-ichi Yoshimura, Shigemi Matsumoto, Masashi Kanai, Megumi Hazama, Hiroshi Ishiguro, Satoshi Nagayama, Kazuhiro Yanagihara, Satoshi Teramukai, Tsutomu Chiba, Yoshiharu Sakai, Masanori Fukushima Yukiko Mori, Takafumi Nishimura, Toshiyuki Kitano, Ken-ichi Yoshimura, Shigemi Matsumoto, Masashi Kanai, Megumi Hazama, Hiroshi Ishiguro, Satoshi Nagayama, Kazuhiro Yanagihara, Satoshi Teramukai, Tsutomu Chiba, Yoshiharu Sakai, Masanori Fukushima Yukiko Mori, Takafumi Nishimura, Toshiyuki Kitano, Ken-ichi Yoshimura, Shigemi Matsumoto, Masashi Kanai, Megumi Hazama, Hiroshi Ishiguro, Satoshi Nagayama, Kazuhiro Yanagihara, Satoshi Teramukai, Tsutomu Chiba, Yoshiharu Sakai, Masanori Fukushima Oxaliplatin-Free Interval as a Risk Factor for Hypersensitivity Reaction among Colorectal Cancer Patients Treated with FOLFOX Oxaliplatin-Free Interval as a Risk Factor for Hypersensitivity Reaction among Colorectal Cancer Patients Treated with FOLFOX Oxaliplatin-Free Interval as a Risk Factor for Hypersensitivity Reaction among Colorectal Cancer Patients Treated with FOLFOX ONCOLOGY, 79, 1-2, 136-143 ONCOLOGY, 79, 1-2, 136-143 ONCOLOGY, 79, 1-2, 136-143 2010 英語 研究論文(学術雑誌) 公開
M. Kanai, S. Morita, S. Matsumoto, T. Nishimura, E. Hatano, S. Yazumi, T. Sasaki, H. Yasuda, T. Kitano, A. Misawa, H. Ishiguro, K. Yanagihara, I. Ikai, R. Doi, M. Fukushima M. Kanai, S. Morita, S. Matsumoto, T. Nishimura, E. Hatano, S. Yazumi, T. Sasaki, H. Yasuda, T. Kitano, A. Misawa, H. Ishiguro, K. Yanagihara, I. Ikai, R. Doi, M. Fukushima M. Kanai, S. Morita, S. Matsumoto, T. Nishimura, E. Hatano, S. Yazumi, T. Sasaki, H. Yasuda, T. Kitano, A. Misawa, H. Ishiguro, K. Yanagihara, I. Ikai, R. Doi, M. Fukushima A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia ANNALS OF ONCOLOGY, 20, 8, 1397-1401 ANNALS OF ONCOLOGY, 20, 8, 1397-1401 ANNALS OF ONCOLOGY, 20, 8, 1397-1401 2009/08 英語 研究論文(学術雑誌) 公開
Masahide Onoue, Tomohiro Terada, Masahiko Kobayashi, Toshiya Katsura, Shigemi Matsumoto, Kazuhiro Yanagihara, Takafumi Nishimura, Masashi Kanai, Satoshi Teramukai, Akira Shimizu, Masanori Fukushima, Ken-ichi Inui Masahide Onoue, Tomohiro Terada, Masahiko Kobayashi, Toshiya Katsura, Shigemi Matsumoto, Kazuhiro Yanagihara, Takafumi Nishimura, Masashi Kanai, Satoshi Teramukai, Akira Shimizu, Masanori Fukushima, Ken-ichi Inui Masahide Onoue, Tomohiro Terada, Masahiko Kobayashi, Toshiya Katsura, Shigemi Matsumoto, Kazuhiro Yanagihara, Takafumi Nishimura, Masashi Kanai, Satoshi Teramukai, Akira Shimizu, Masanori Fukushima, Ken-ichi Inui UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 14, 2, 136-142 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 14, 2, 136-142 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 14, 2, 136-142 2009/04 英語 研究論文(学術雑誌) 公開
Junichi Yamauchi, Masashi Kanai, Shigemi Matsumoto, Takafumi Nishimura, Shujiro Yazumi, Kazuhiro Kami, Yoshiya Kawaguchi, Hiroyasu Yasuda, Toshiyuki Kitano, Akiko Misawa, Hiroshi Ishiguro, Kiyotsugu Yoshikawa, Kazuhiro Yanagihara, Masanori Fukushima, Ryuichiro Doi, Tsutomu Chiba Junichi Yamauchi, Masashi Kanai, Shigemi Matsumoto, Takafumi Nishimura, Shujiro Yazumi, Kazuhiro Kami, Yoshiya Kawaguchi, Hiroyasu Yasuda, Toshiyuki Kitano, Akiko Misawa, Hiroshi Ishiguro, Kiyotsugu Yoshikawa, Kazuhiro Yanagihara, Masanori Fukushima, Ryuichiro Doi, Tsutomu Chiba Junichi Yamauchi, Masashi Kanai, Shigemi Matsumoto, Takafumi Nishimura, Shujiro Yazumi, Kazuhiro Kami, Yoshiya Kawaguchi, Hiroyasu Yasuda, Toshiyuki Kitano, Akiko Misawa, Hiroshi Ishiguro, Kiyotsugu Yoshikawa, Kazuhiro Yanagihara, Masanori Fukushima, Ryuichiro Doi, Tsutomu Chiba Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer PANCREAS, 36, 3, 327-328 PANCREAS, 36, 3, 327-328 PANCREAS, 36, 3, 327-328 2008/04 英語 公開
Shigemi Matsumoto, Takafumi Nishimura, Masashi Kanai, Yukiko Mori, Satoshi Nagayama, Jun'ichiro Kawamura, Akinari Nomura, Shin'ichi Miyamoto, Toshiyuki Kitano, Hiroshi Ishiguro, Kazuhiro Yanagihara, Satoshi Teramukai, Yoshiharu Sakai, Tsutomu Chiba, Masanori Fukushima Shigemi Matsumoto, Takafumi Nishimura, Masashi Kanai, Yukiko Mori, Satoshi Nagayama, Jun'ichiro Kawamura, Akinari Nomura, Shin'ichi Miyamoto, Toshiyuki Kitano, Hiroshi Ishiguro, Kazuhiro Yanagihara, Satoshi Teramukai, Yoshiharu Sakai, Tsutomu Chiba, Masanori Fukushima Shigemi Matsumoto, Takafumi Nishimura, Masashi Kanai, Yukiko Mori, Satoshi Nagayama, Jun'ichiro Kawamura, Akinari Nomura, Shin'ichi Miyamoto, Toshiyuki Kitano, Hiroshi Ishiguro, Kazuhiro Yanagihara, Satoshi Teramukai, Yoshiharu Sakai, Tsutomu Chiba, Masanori Fukushima Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer CHEMOTHERAPY, 54, 5, 395-403 CHEMOTHERAPY, 54, 5, 395-403 CHEMOTHERAPY, 54, 5, 395-403 2008 英語 研究論文(学術雑誌) 公開
Toshiyuki Kitano, Harue Tada, Tsutomu Nishimura, Satoshi Teramukai, Masashi Kanai, Takafumi Nishimura, Akiko Misawa, Kiyotsugu Yoshikawa, Hiroyasu Yasuda, Hiroshi Ishiguro, Shigemi Matsumoto, Kazuhiro Yanagihara, Masanori Fukushima Toshiyuki Kitano, Harue Tada, Tsutomu Nishimura, Satoshi Teramukai, Masashi Kanai, Takafumi Nishimura, Akiko Misawa, Kiyotsugu Yoshikawa, Hiroyasu Yasuda, Hiroshi Ishiguro, Shigemi Matsumoto, Kazuhiro Yanagihara, Masanori Fukushima Toshiyuki Kitano, Harue Tada, Tsutomu Nishimura, Satoshi Teramukai, Masashi Kanai, Takafumi Nishimura, Akiko Misawa, Kiyotsugu Yoshikawa, Hiroyasu Yasuda, Hiroshi Ishiguro, Shigemi Matsumoto, Kazuhiro Yanagihara, Masanori Fukushima Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapy Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapy Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapy INTERNATIONAL JOURNAL OF HEMATOLOGY, 86, 1, 37-41 INTERNATIONAL JOURNAL OF HEMATOLOGY, 86, 1, 37-41 INTERNATIONAL JOURNAL OF HEMATOLOGY, 86, 1, 37-41 2007/07 英語 研究論文(学術雑誌) 公開
Masashi Kanai, Shigemi Matsumoto, Takahumi Nishimura, Yutaka Shimada, Go Watanabe, Toshiyuki Kitano, Akiko Misawa, Hiroshi Ishiguro, Kiyotsugu Yoshikawa, Kazuhiro Yanagihara, Satoshi Teramukai, Michihide Mitsumori, Tsutomu Chiba, Yoshiharu Sakai, Masanori Fukushima Masashi Kanai, Shigemi Matsumoto, Takahumi Nishimura, Yutaka Shimada, Go Watanabe, Toshiyuki Kitano, Akiko Misawa, Hiroshi Ishiguro, Kiyotsugu Yoshikawa, Kazuhiro Yanagihara, Satoshi Teramukai, Michihide Mitsumori, Tsutomu Chiba, Yoshiharu Sakai, Masanori Fukushima Masashi Kanai, Shigemi Matsumoto, Takahumi Nishimura, Yutaka Shimada, Go Watanabe, Toshiyuki Kitano, Akiko Misawa, Hiroshi Ishiguro, Kiyotsugu Yoshikawa, Kazuhiro Yanagihara, Satoshi Teramukai, Michihide Mitsumori, Tsutomu Chiba, Yoshiharu Sakai, Masanori Fukushima Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophagealcancer Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophagealcancer Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophagealcancer INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 12, 3, 224-227 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 12, 3, 224-227 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 12, 3, 224-227 2007/06 英語 研究論文(学術雑誌) 公開
Kanai M Kanai M Masashi Kanai, Daoyan Wei, Qiang Li, Zhiliang Jia, Jaffer Ajani, Xiangdong Le, James Yao, Keping Xie Loss of Krüppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progression Loss of Krüppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progression Loss of Kruppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progression Clin Cancer Res. 2006 Nov 1;12(21):6395-402, 12, 21, 6395-6402 Clin Cancer Res. 2006 Nov 1;12(21):6395-402, 12, 21, 6395-6402 CLINICAL CANCER RESEARCH, 12, 21, 6395-6402 2006/11 英語 研究論文(学術雑誌) 公開
Wei D, Gong W, Kanai M, Schlunk C, Wang L, Yao JC, Wu TT, Huang S, Xie K Wei D, Gong W, Kanai M, Schlunk C, Wang L, Yao JC, Wu TT, Huang S, Xie K DY Wei, WD Gong, M Kanai, C Schlunk, LW Wang, JC Yao, TT Wu, SY Huang, KP Xie Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression. Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression. Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression Cancer research, 65, 7, 2746-2754 Cancer research, 65, 7, 2746-2754 CANCER RESEARCH, 65, 7, 2746-2754 2005/04 英語 研究論文(学術雑誌) 公開
Kanai M, Torii A, Hamada A, Endo Y, Takeda Y, Yamakawa M, Hikita H, Nishikawa H, Ochi J, Miura K, Noguchi M, Kashu I, Sakurai T Kanai M, Torii A, Hamada A, Endo Y, Takeda Y, Yamakawa M, Hikita H, Nishikawa H, Ochi J, Miura K, Noguchi M, Kashu I, Sakurai T M. Kanai, A. Torii, A. Hamada, Y. Endo, Y. Takeda, M. Yamakawa, H. Hikita, H. Nishikawa, J. Ochi, K. Miura, M. Noguchi, I. Kashu, T. Sakurai Pure gastric yolk sac tumor that was diagnosed after curative resection: case report and review of literature. Pure gastric yolk sac tumor that was diagnosed after curative resection: case report and review of literature. Pure gastric yolk sac tumor that was diagnosed after curative resection: Case report and review of literature International journal of gastrointestinal cancer, 35, 1, 77-81 International journal of gastrointestinal cancer, 35, 1, 77-81 International Journal of Gastrointestinal Cancer, 35, 1, 77-81 2005 英語 公開
M Kanai, A Hamada, Y Endo, Y Takeda, M Yamakawa, H Nishikawa, A Torii M Kanai, A Hamada, Y Endo, Y Takeda, M Yamakawa, H Nishikawa, A Torii M Kanai, A Hamada, Y Endo, Y Takeda, M Yamakawa, H Nishikawa, A Torii Efficacy of argon plasma coagulation in nonvariceal upper gastrointestinal bleeding Efficacy of argon plasma coagulation in nonvariceal upper gastrointestinal bleeding Efficacy of argon plasma coagulation in nonvariceal upper gastrointestinal bleeding ENDOSCOPY, 36, 12, 1085-1088 ENDOSCOPY, 36, 12, 1085-1088 ENDOSCOPY, 36, 12, 1085-1088 2004/12 英語 研究論文(学術雑誌) 公開
N Kanda, H Seno, Y Konda, H Marusawa, M Kanai, T Nakajima, T Kawashima, A Nanakin, T Sawabu, Y Uenoyama, A Sekikawa, M Kawada, K Suzuki, T Kayahara, H Fukui, M Sawada, T Chiba N Kanda, H Seno, Y Konda, H Marusawa, M Kanai, T Nakajima, T Kawashima, A Nanakin, T Sawabu, Y Uenoyama, A Sekikawa, M Kawada, K Suzuki, T Kayahara, H Fukui, M Sawada, T Chiba N Kanda, H Seno, Y Konda, H Marusawa, M Kanai, T Nakajima, T Kawashima, A Nanakin, T Sawabu, Y Uenoyama, A Sekikawa, M Kawada, K Suzuki, T Kayahara, H Fukui, M Sawada, T Chiba STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells ONCOGENE, 23, 28, 4921-4929 ONCOGENE, 23, 28, 4921-4929 ONCOGENE, 23, 28, 4921-4929 2004/06 英語 研究論文(学術雑誌) 公開
Ogasawara M, Kanai M, Tada E, Oe K, Hamada A, Endo Y, Yamakawa M, Takeda Y, Torii A, Hikita H, Matsubayashi Y, Nishikawa H, Ochi J, Miura K Ogasawara M, Kanai M, Tada E, Oe K, Hamada A, Endo Y, Yamakawa M, Takeda Y, Torii A, Hikita H, Matsubayashi Y, Nishikawa H, Ochi J, Miura K M. Ogasawara, M. Kanai, E. Tada, K. Oe, A. Hamada, Y. Endo, M. Yamakawa, Y. Takeda, A. Torii, H. Hikita, Y. Matsubayashi, H. Nishikawa, J. Ochi, K. Miura [A case of effective weekly paclitaxel administration for primary lesion of schirrous gastric cancer]. [A case of effective weekly paclitaxel administration for primary lesion of schirrous gastric cancer]. A case of effective weekly paclitaxel administration for primary lesion of schirrous gastric cancer Gan to kagaku ryoho. Cancer & chemotherapy, 31, 1, 91-93 Gan to kagaku ryoho. Cancer & chemotherapy, 31, 1, 91-93 Gan to kagaku ryoho. Cancer & chemotherapy, 31, 1, 91-93 2004/01 英語 公開
M Kanai, Y Konda, T Nakajaima, Y Izumi, N Kanda, A Nanakin, Y Kubohara, T Chiba M Kanai, Y Konda, T Nakajaima, Y Izumi, N Kanda, A Nanakin, Y Kubohara, T Chiba M Kanai, Y Konda, T Nakajaima, Y Izumi, N Kanda, A Nanakin, Y Kubohara, T Chiba Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway ONCOGENE, 22, 4, 548-554 ONCOGENE, 22, 4, 548-554 ONCOGENE, 22, 4, 548-554 2003/01 英語 研究論文(学術雑誌) 公開
T Nakajima, Y Konda, M Kanai, Y Izumi, N Kanda, A Nanakin, S Kitazawa, T Chiba T Nakajima, Y Konda, M Kanai, Y Izumi, N Kanda, A Nanakin, S Kitazawa, T Chiba T Nakajima, Y Konda, M Kanai, Y Izumi, N Kanda, A Nanakin, S Kitazawa, T Chiba Prohormone convertase furin has a role in gastric cancer cell proliferation with parathyroid hormone-related peptide in a reciprocal manner Prohormone convertase furin has a role in gastric cancer cell proliferation with parathyroid hormone-related peptide in a reciprocal manner Prohormone convertase furin has a role in gastric cancer cell proliferation with parathyroid hormone-related peptide in a reciprocal manner DIGESTIVE DISEASES AND SCIENCES, 47, 12, 2729-2737 DIGESTIVE DISEASES AND SCIENCES, 47, 12, 2729-2737 DIGESTIVE DISEASES AND SCIENCES, 47, 12, 2729-2737 2002/12 英語 研究論文(学術雑誌) 公開
T Nakajima, Y Konda, Y Izumi, M Kanai, T Takeuchi, T Chiba T Nakajima, Y Konda, Y Izumi, M Kanai, T Takeuchi, T Chiba T Nakajima, Y Konda, Y Izumi, M Kanai, T Takeuchi, T Chiba Gastrin interferes with the differentiation of gastric pit cells and parietal cells Gastrin interferes with the differentiation of gastric pit cells and parietal cells Gastrin interferes with the differentiation of gastric pit cells and parietal cells ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 16, 2, 3-9 ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 16, 2, 3-9 ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 16, 2, 3-9 2002/04 英語 研究論文(学術雑誌) 公開
Nakajima T, Konda Y, Izumi Y, Kanai M, Hayashi N, Chiba T, Takeuchi T Nakajima T, Konda Y, Izumi Y, Kanai M, Hayashi N, Chiba T, Takeuchi T T. Nakajima, Y. Konda, Y. Izumi, M. Kanai, N. Hayashi, T. Chiba, T. Takeuchi Gastrin stimulates the growth of gastric pit cell precursors by inducing its own receptors. Gastrin stimulates the growth of gastric pit cell precursors by inducing its own receptors. Gastrin stimulates the growth of gastric pit cell precursors by inducing its own receptors American journal of physiology. Gastrointestinal and liver physiology, 282, 2, G359-66 American journal of physiology. Gastrointestinal and liver physiology, 282, 2, G359-66 American Journal of Physiology - Gastrointestinal and Liver Physiology, 282, 2, G359-66 2002/02 英語 公開
M Kanai, Y Konda, T Nakajima, Y Izumi, T Takeuchi, T Chiba M Kanai, Y Konda, T Nakajima, Y Izumi, T Takeuchi, T Chiba M Kanai, Y Konda, T Nakajima, Y Izumi, T Takeuchi, T Chiba TGF-alpha inhibits apoptosis of murine gastric pit cells through an NF-kappa B-dependent pathway TGF-alpha inhibits apoptosis of murine gastric pit cells through an NF-kappa B-dependent pathway TGF-alpha inhibits apoptosis of murine gastric pit cells through an NF-kappa B-dependent pathway GASTROENTEROLOGY, 121, 1, 56-67 GASTROENTEROLOGY, 121, 1, 56-67 GASTROENTEROLOGY, 121, 1, 56-67 2001/07 英語 研究論文(学術雑誌) 公開
M Kanai, Y Konda, T Nakajima, Y Izumi, T Takeuchi, T Chiba M Kanai, Y Konda, T Nakajima, Y Izumi, T Takeuchi, T Chiba M Kanai, Y Konda, T Nakajima, Y Izumi, T Takeuchi, T Chiba TGF-alpha inhibits apoptosis of murine gastric pit cells through an NF-kappa B-dependent pathway TGF-alpha inhibits apoptosis of murine gastric pit cells through an NF-kappa B-dependent pathway TGF-alpha inhibits apoptosis of murine gastric pit cells through an NF-kappa B-dependent pathway GASTROENTEROLOGY, 121, 1, 56-67 GASTROENTEROLOGY, 121, 1, 56-67 GASTROENTEROLOGY, 121, 1, 56-67 2001/07 英語 研究論文(学術雑誌) 公開

  • <<
  • >>
  • 表示
タイトル言語:
Misc
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 書誌情報等 書誌情報等(日本語) 書誌情報等(英語) 出版年月 査読の有無 記述言語 掲載種別 公開
金井 雅史 金井 雅史 京都大学病院がんセンターキャンサーバイオバンクプロジェクト 京都大学病院がんセンターキャンサーバイオバンクプロジェクト 第12回日本臨床腫瘍学会学術集会 2014/7/17 福岡 第12回日本臨床腫瘍学会学術集会 2014/7/17 福岡 2014/07 会議報告等 公開
金井 雅史 金井 雅史 膵がん治療におけるクルクミンの可能性 膵がん治療におけるクルクミンの可能性 第14回 日本 抗加齢医学会総会 ランチョンセミナー 2014/6/7 第14回 日本 抗加齢医学会総会 ランチョンセミナー 2014/6/7 2014/06 公開
金井 雅史 金井 雅史 胆道癌治療における化学療法の役割と個別化への展望 胆道癌治療における化学療法の役割と個別化への展望 第26回 日本肝胆膵外科学会 モーニングセミナー 2014/6/12 第26回 日本肝胆膵外科学会 モーニングセミナー 2014/6/12 2014/06 公開
金井 雅史 金井 雅史 KHBOのこれまでの成果と今後の取り組み KHBOのこれまでの成果と今後の取り組み 胆道がん治療研究会 2014/5/9 大阪 胆道がん治療研究会 2014/5/9 大阪 2014/05 公開
Masashi Kanai Masashi Kanai Masashi Kanai Therapeutic application of highly bioavailable curcumin for patients with cancer Therapeutic application of highly bioavailable curcumin for patients with cancer Therapeutic application of highly bioavailable curcumin for patients with cancer GAP meeting, May 1-3, 2014, Seul, Korea GAP meeting, May 1-3, 2014, Seul, Korea GAP meeting, May 1-3, 2014, Seul, Korea 2014/05 英語 会議報告等 公開
金井 雅史 金井 雅史 がん治療におけるクルクミンの可能性 がん治療におけるクルクミンの可能性 第134年会日本薬学会 一般シンポジウム 2014/3/28 熊本 第134年会日本薬学会 一般シンポジウム 2014/3/28 熊本 2014/03 公開
金井 雅史 金井 雅史 ここまで進んだ大腸癌分子標的治療 ここまで進んだ大腸癌分子標的治療 第17回がん分子標的治療学会学術集会 市民公開講座 2013/6/15 京都 第17回がん分子標的治療学会学術集会 市民公開講座 2013/6/15 京都 2013/06 公開
金井 雅史 金井 雅史 大腸がん治療におけるアバスチンの役割 大腸がん治療におけるアバスチンの役割 第17回 Kyoto Breast Consensus Conference 2013/4/27 京都 第17回 Kyoto Breast Consensus Conference 2013/4/27 京都 2013/04 公開
Masashi Kanai Masashi Kanai Masashi Kanai Establishment of Kyoto University Cancer Center Biobank Establishment of Kyoto University Cancer Center Biobank Establishment of Kyoto University Cancer Center Biobank GAP meeting, April 3-5 2013, Houston, USA GAP meeting, April 3-5 2013, Houston, USA GAP meeting, April 3-5 2013, Houston, USA 2013/04 英語 会議報告等 公開
Masashi Kanai Masashi Kanai Masashi Kanai A phase I study investigating the safety and pharamakokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients A phase I study investigating the safety and pharamakokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients A phase I study investigating the safety and pharamakokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients ASCO Gastrointestional Cancers Symposium, Jan.24-26,2013,Sanfrancisco, USA ASCO Gastrointestional Cancers Symposium, Jan.24-26,2013,Sanfrancisco, USA ASCO Gastrointestional Cancers Symposium, Jan.24-26,2013,Sanfrancisco, USA 2013/01 英語 会議報告等 公開
金井 雅史 金井 雅史 ゲムシタビンに抵抗性となった膵癌・胆道癌患者に対するナノ化クルクミン療法の第Ⅰ相臨床試験 ゲムシタビンに抵抗性となった膵癌・胆道癌患者に対するナノ化クルクミン療法の第Ⅰ相臨床試験 日本臨床腫瘍学会 2012/7/26 大阪 日本臨床腫瘍学会 2012/7/26 大阪 2012/07 公開
Masashi Kanai Masashi Kanai Masashi Kanai Phase I study of nanoparticle curcumin, a potential anti-cancer agents with improved bioavailability, for patients with cancer who failed standard chemotherapy. Phase I study of nanoparticle curcumin, a potential anti-cancer agents with improved bioavailability, for patients with cancer who failed standard chemotherapy. Phase I study of nanoparticle curcumin, a potential anti-cancer agents with improved bioavailability, for patients with cancer who failed standard chemotherapy. GAP meeting, May 13-15, 2012, Oslo, Norway GAP meeting, May 13-15, 2012, Oslo, Norway GAP meeting, May 13-15, 2012, Oslo, Norway 2012/05 英語 会議報告等 公開
Masashi Kanai Masashi Kanai Masashi Kanai Association of temporary blood pressure drop after bevacizumab administration with clinical course of advanced colorectal cancer Association of temporary blood pressure drop after bevacizumab administration with clinical course of advanced colorectal cancer Association of temporary blood pressure drop after bevacizumab administration with clinical course of advanced colorectal cancer Gatrointestinal Cancers Symposium, Jan.21, 2012, San francisco, USA Gatrointestinal Cancers Symposium, Jan.21, 2012, San francisco, USA Gatrointestinal Cancers Symposium, Jan.21, 2012, San francisco, USA 2012/01 英語 会議報告等 公開
Masashi Kanai Masashi Kanai Masashi Kanai The potential role of curcumin for treatment of pancreatic cancer The potential role of curcumin for treatment of pancreatic cancer The potential role of curcumin for treatment of pancreatic cancer Conference 2011, Nov.17, 2011, Sapporo, Japan Conference 2011, Nov.17, 2011, Sapporo, Japan Conference 2011, Nov.17, 2011, Sapporo, Japan 2011/11 英語 会議報告等 公開
金井 雅史 金井 雅史 大腸癌個別化治療確立を目指したゲノム薬理学研究 大腸癌個別化治療確立を目指したゲノム薬理学研究 第81回日本消化器内視鏡学会総会 ワークショップ 2011/8/17 名古屋 第81回日本消化器内視鏡学会総会 ワークショップ 2011/8/17 名古屋 2011/08 公開
金井 雅史 金井 雅史 細粒化クルクミンを用いた新規癌治療法の開発 細粒化クルクミンを用いた新規癌治療法の開発 第11回日本抗加齢医学会総会 2011/5/27 京都 第11回日本抗加齢医学会総会 2011/5/27 京都 2011/05 公開
金井 雅史 金井 雅史 ゲムシタビンによる皮疹とその対策 ゲムシタビンによる皮疹とその対策 第2回京都胆道カンファランス 2011/1/13 京都 第2回京都胆道カンファランス 2011/1/13 京都 2011/01 公開
金井 雅史 金井 雅史 クルクミンを用いた新規癌治療法の開発 クルクミンを用いた新規癌治療法の開発 日本消化器病学会総会 シンポジウム 2010/10/15 横浜 日本消化器病学会総会 シンポジウム 2010/10/15 横浜 2010/10 公開
Masashi Kanai Masashi Kanai Masashi Kanai A Phase I / II Study of Complementary Therapy Using Curcumin for Pancreatic Cancer Patients Who Get Resistant to Gemcitabine-Based Chemotherapy. A Phase I / II Study of Complementary Therapy Using Curcumin for Pancreatic Cancer Patients Who Get Resistant to Gemcitabine-Based Chemotherapy. A Phase I / II Study of Complementary Therapy Using Curcumin for Pancreatic Cancer Patients Who Get Resistant to Gemcitabine-Based Chemotherapy. Annual Conference 2010, Oct.13, 2010, Bali, Indonesia Annual Conference 2010, Oct.13, 2010, Bali, Indonesia Annual Conference 2010, Oct.13, 2010, Bali, Indonesia 2010/10 英語 会議報告等 公開
金井 雅史 金井 雅史 切除不能進行胆道癌に対するゲムシタビン/S-1併用療法の治療成績 切除不能進行胆道癌に対するゲムシタビン/S-1併用療法の治療成績 第1回京都胆道カンファランス 2010年6月 京都 第1回京都胆道カンファランス 2010年6月 京都 2010/06 公開
金井 雅史 金井 雅史 切除不能胆道癌に対するgemcitabin+S-1併用療法の第Ⅱ相臨床試験(最終結果) 切除不能胆道癌に対するgemcitabin+S-1併用療法の第Ⅱ相臨床試験(最終結果) 日本臨床腫瘍学会 2010/3/18 東京 日本臨床腫瘍学会 2010/3/18 東京 2010/03 公開
Masashi Kanai Masashi Kanai Masashi Kanai Smoking history inhibits the incidence of neutropenia during gemcitabine monotherapy in cancer patients Smoking history inhibits the incidence of neutropenia during gemcitabine monotherapy in cancer patients Smoking history inhibits the incidence of neutropenia during gemcitabine monotherapy in cancer patients Keystone Symposia, March 24, 2009, Vancouver, Canada Keystone Symposia, March 24, 2009, Vancouver, Canada Keystone Symposia, March 24, 2009, Vancouver, Canada 2009/03 英語 会議報告等 公開
金井 雅史 金井 雅史 ゲムシタビン投与患者における好中球減少症と喫煙の関係 ゲムシタビン投与患者における好中球減少症と喫煙の関係 第4回京都膵臓カンファランス 2009年2月 京都 第4回京都膵臓カンファランス 2009年2月 京都 2009/02 公開
金井 雅史 金井 雅史 膵癌患者に対するクルクミン補助療法の第Ⅰ/Ⅱ相臨床試験 膵癌患者に対するクルクミン補助療法の第Ⅰ/Ⅱ相臨床試験 平安京漢方医学セミナー 2009年2月 京都 平安京漢方医学セミナー 2009年2月 京都 2009/02 公開
金井 雅史 金井 雅史 最近の消化器癌化学療法の進歩 最近の消化器癌化学療法の進歩 西宮市内科医会学術講演会 2008年3月 西宮 西宮市内科医会学術講演会 2008年3月 西宮 2008/03 公開
金井 雅史 金井 雅史 進行・再発食道癌に対するセカンドライン化学療法としてのドセタキセル/ネダプラチン併用療法の治療成績 進行・再発食道癌に対するセカンドライン化学療法としてのドセタキセル/ネダプラチン併用療法の治療成績 日本臨床腫瘍学会 2007/3/24 札幌 日本臨床腫瘍学会 2007/3/24 札幌 2007/03 公開
Masashi Kanai Masashi Kanai Masashi Kanai The efficacy and safety of docetaxel/nedaplatin combination therapy as a second line regimen in advanced esophageal cancer The efficacy and safety of docetaxel/nedaplatin combination therapy as a second line regimen in advanced esophageal cancer The efficacy and safety of docetaxel/nedaplatin combination therapy as a second line regimen in advanced esophageal cancer ASCO Gastrointestional Cancers Symposium, Jan.19, 2007, Orlando, USA ASCO Gastrointestional Cancers Symposium, Jan.19, 2007, Orlando, USA ASCO Gastrointestional Cancers Symposium, Jan.19, 2007, Orlando, USA 2007/01 英語 会議報告等 公開
金井 雅史 金井 雅史 がん化学療法の最近の進歩と展望 がん化学療法の最近の進歩と展望 京都桂病院 2006/12 京都 京都桂病院 2006/12 京都 2006/12 公開
Masashi Kanai Masashi Kanai Masashi Kanai KLF4 can negatively regulate Sp1 expressin in gatric cancer cells KLF4 can negatively regulate Sp1 expressin in gatric cancer cells KLF4 can negatively regulate Sp1 expressin in gatric cancer cells International Gastrointestinal Cancer Reasearch Meeting, July 2005, Washington DC, USA International Gastrointestinal Cancer Reasearch Meeting, July 2005, Washington DC, USA International Gastrointestinal Cancer Reasearch Meeting, July 2005, Washington DC, USA 2005/07 英語 書評、文献紹介等 公開
金井 雅史 金井 雅史 根治的治療がなされたにもかかわらず早期に再発を認めた胃 yolk sac 腫瘍の一例 根治的治療がなされたにもかかわらず早期に再発を認めた胃 yolk sac 腫瘍の一例 日本消化器病学会 2003 大宮 日本消化器病学会 2003 大宮 2003 公開
金井 雅史 金井 雅史 食道静脈瘤に対する内視鏡的静脈瘤密集結紮術(EVTL)単独療法の治療成績 食道静脈瘤に対する内視鏡的静脈瘤密集結紮術(EVTL)単独療法の治療成績 日本消化器内視鏡病学会 2003 博多 日本消化器内視鏡病学会 2003 博多 2003 公開
金井 雅史 金井 雅史 上部消化管出血に対するアルゴンプラズマ凝固療法(APC)の有用性ーエビデンスに基づいた治療効果検討 上部消化管出血に対するアルゴンプラズマ凝固療法(APC)の有用性ーエビデンスに基づいた治療効果検討 日本消化器病学会総会 シンポジウム 2003年 大阪 日本消化器病学会総会 シンポジウム 2003年 大阪 2003 公開
金井 雅史 金井 雅史 当院における食道癌症例の治療の現状 当院における食道癌症例の治療の現状 日本消化器病学会 2002 旭川 日本消化器病学会 2002 旭川 2002 公開
Masashi Kanai Masashi Kanai Masashi Kanai Differentiation inducing factor-1(DIF-1) and its analogs prevent proliferation of gastric cancer cell lines. Differentiation inducing factor-1(DIF-1) and its analogs prevent proliferation of gastric cancer cell lines. Differentiation inducing factor-1(DIF-1) and its analogs prevent proliferation of gastric cancer cell lines. Digestive Disease Week, May 2001, Atlanta, USA Digestive Disease Week, May 2001, Atlanta, USA Digestive Disease Week, May 2001, Atlanta, USA 2001/05 英語 会議報告等 公開
Masashi Kanai Masashi Kanai Masashi Kanai NF-kappa B activation by transforming growth factor alpha (TGF-alpha) prevents apoptosis of gatstric mucosal cell. NF-kappa B activation by transforming growth factor alpha (TGF-alpha) prevents apoptosis of gatstric mucosal cell. NF-kappa B activation by transforming growth factor alpha (TGF-alpha) prevents apoptosis of gatstric mucosal cell. Digestive Disease Week, May 2000, San Diego, USA Digestive Disease Week, May 2000, San Diego, USA Digestive Disease Week, May 2000, San Diego, USA 2000/05 英語 会議報告等 公開
金井 雅史 金井 雅史 培養胃粘膜細胞におけるTGF-αの抗アポトーシス効果に対するNSAIDsの作用 培養胃粘膜細胞におけるTGF-αの抗アポトーシス効果に対するNSAIDsの作用 日本消化器病学会総会 2000 神戸 日本消化器病学会総会 2000 神戸 2000 公開
金井 雅史 金井 雅史 TGF-αによるNF-κBを介した胃粘膜上皮細胞に対する抗アポトーシス作用 TGF-αによるNF-κBを介した胃粘膜上皮細胞に対する抗アポトーシス作用 日本消化器病学会総会 2000 新潟 日本消化器病学会総会 2000 新潟 2000 公開
金井 雅史 金井 雅史 柄細胞分化誘導因子(DIF-1)によるAkt/protein kinase B を介した胃癌細胞増殖抑制作用 柄細胞分化誘導因子(DIF-1)によるAkt/protein kinase B を介した胃癌細胞増殖抑制作用 日本消化器病学会総会 1999 広島 日本消化器病学会総会 1999 広島 1999 公開

  • <<
  • >>
  • 表示
タイトル言語:
講演・口頭発表等
タイトル タイトル(日本語) タイトル(英語) 会議名 会議名(日本語) 会議名(英語) 主催者 主催者(日本語) 主催者(英語) 開催年月日 記述言語 会議種別 公開
Therapeutic application of highly bioavailable curcumin for patients with cancer[招待あり] Therapeutic application of highly bioavailable curcumin for patients with cancer [招待あり] Therapeutic application of highly bioavailable curcumin for patients with cancer [招待あり] The second International Conference on Pharma and Food, Shizuoka The second International Conference on Pharma and Food, Shizuoka The second International Conference on Pharma and Food, Shizuoka 2014/11/05 公開
The current gideline of pancreatic cancer in Japan[招待あり] The current gideline of pancreatic cancer in Japan [招待あり] The current gideline of pancreatic cancer in Japan [招待あり] Shanghai International Conference on Pancreatic Cancer Shanghai International Conference on Pancreatic Cancer Shanghai International Conference on Pancreatic Cancer 2014/08/01 英語 公開
がん薬物療法における個別化医療の展望 招待講演[招待あり] がん薬物療法における個別化医療の展望 招待講演 [招待あり] 京都桂消化器懇話会 京都桂消化器懇話会 2014/03/13 公開
がん治療におけるクルクミンの可能性 招待講演[招待あり] がん治療におけるクルクミンの可能性 招待講演 [招待あり] 第9回 日本食品免疫学会 東京 第9回 日本食品免疫学会 東京 2013/10 公開
より安全で確実な効果を目指した胆膵悪性腫瘍に対する化学療法[招待あり] より安全で確実な効果を目指した胆膵悪性腫瘍に対する化学療法 [招待あり] 秋田肝胆膵癌研究会 秋田肝胆膵癌研究会 2011/10/15 日本語 口頭発表(招待・特別) 公開
Japanese experience in pancreatic cancer management[招待あり] Japanese experience in pancreatic cancer management [招待あり] Japanese experience in pancreatic cancer management [招待あり] Shanghai International Conference on Pancreatic Cancer, Shanghai, China Shanghai International Conference on Pancreatic Cancer, Shanghai, China Shanghai International Conference on Pancreatic Cancer, Shanghai, China 2011/08/13 英語 口頭発表(招待・特別) 公開
分子標的薬剤を用いた消化器がん化学療法の現状[招待あり] 分子標的薬剤を用いた消化器がん化学療法の現状 [招待あり] 第16回 (社)伏見医師会癌医療病診連携の会 第16回 (社)伏見医師会癌医療病診連携の会 2010/11/27 日本語 口頭発表(招待・特別) 公開
A Phase I/II Study of Complementary Therapy Using Curcumin for Pancreatic Cancer Patients Who Get Refractory to Gemcitabine-Based Chemotherapy[招待あり] A Phase I/II Study of Complementary Therapy Using Curcumin for Pancreatic Cancer Patients Who Get Refractory to Gemcitabine-Based Chemotherapy [招待あり] A Phase I/II Study of Complementary Therapy Using Curcumin for Pancreatic Cancer Patients Who Get Refractory to Gemcitabine-Based Chemotherapy [招待あり] The 3rd World Cancer Congress, Singapore The 3rd World Cancer Congress, Singapore The 3rd World Cancer Congress, Singapore 2010/06/23 英語 口頭発表(招待・特別) 公開
Pharmacogenetic approach to predicting clinical response of chemotherapy in advanced colorectal cancer[招待あり] Pharmacogenetic approach to predicting clinical response of chemotherapy in advanced colorectal cancer [招待あり] Pharmacogenetic approach to predicting clinical response of chemotherapy in advanced colorectal cancer [招待あり] Organisation for Oncology and Translational Research conference, Kyoto Organisation for Oncology and Translational Research conference, Kyoto Organisation for Oncology and Translational Research conference, Kyoto 2010/02 英語 口頭発表(招待・特別) 公開
Advances in Gastric Cancer Diagnosis and Treatment in Japan[招待あり] Advances in Gastric Cancer Diagnosis and Treatment in Japan [招待あり] Advances in Gastric Cancer Diagnosis and Treatment in Japan [招待あり] Symposium on Tumor-Targeted Therapy, Shanghai Symposium on Tumor-Targeted Therapy, Shanghai Symposium on Tumor-Targeted Therapy, Shanghai 2006/08 公開
タイトル言語:
書籍等出版物
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 出版社 出版社(日本語) 出版社(英語) 出版年月 記述言語 担当区分 公開
金井 雅史 金井 雅史 ファーマコゲノミクス解析による治療体系 ファーマコゲノミクス解析による治療体系 日本臨床 日本臨床 2014 公開
金井 雅史 金井 雅史 抗がん剤のファーマコゲノミクス 抗がん剤のファーマコゲノミクス 血液内科 血液内科 2014 公開
金井 雅史 金井 雅史 GEM-1併用療法による切除不能胆道癌の治療成績 GEM-1併用療法による切除不能胆道癌の治療成績 肝胆膵 肝胆膵 2012 公開
金井 雅史 金井 雅史 膵がん領域におけるmiRNA研究 膵がん領域におけるmiRNA研究 遺伝子医学Mook 遺伝子医学Mook 2012 公開
金井 雅史 金井 雅史 乳癌の薬物療法(主にアバスチン)と血圧管理 乳癌の薬物療法(主にアバスチン)と血圧管理 CancerBoard 乳癌 CancerBoard 乳癌 2012 公開
Kanai M, Guha S, Aggarwal BB Kanai M, Guha S, Aggarwal BB Kanai M, Guha S, Aggarwal BB The potential role of curcumin for treatment of pancreatic cancer The potential role of curcumin for treatment of pancreatic cancer The potential role of curcumin for treatment of pancreatic cancer Pancreatic Cancer / Book 2 , ISBN 979-953-307-701-6 in press Pancreatic Cancer / Book 2 , ISBN 979-953-307-701-6 in press Pancreatic Cancer / Book 2 , ISBN 979-953-307-701-6 in press 2011 英語 公開
金井雅史, 松本繫巳, 千葉 勉 金井雅史, 松本繫巳, 千葉 勉 遺伝子多型解析は消化器癌化学療法にどのように役立つのか 遺伝子多型解析は消化器癌化学療法にどのように役立つのか 分子消化器病 分子消化器病 2011 日本語 公開
Kanai M Kanai M Kanai M The potential role of curcumin as a chemotherapeutic drug The potential role of curcumin as a chemotherapeutic drug The potential role of curcumin as a chemotherapeutic drug Advances in Food Science and Technology in press Advances in Food Science and Technology in press Advances in Food Science and Technology in press 2011 英語 公開
金井 雅史 金井 雅史 消化器癌治療薬選択のための遺伝子検査 消化器癌治療薬選択のための遺伝子検査 分子消化器病 分子消化器病 2010 日本語 公開
金井 雅史 金井 雅史 胆道癌補助化学療法の実際 胆道癌補助化学療法の実際 外科治療 外科治療 2010 公開
金井 雅史 金井 雅史 最近の消化器癌化学療法の進歩 - 大腸癌化学療法を中心に 最近の消化器癌化学療法の進歩 - 大腸癌化学療法を中心に 西宮医師会雑誌 西宮医師会雑誌 2009 公開
金井 雅史 金井 雅史 膵癌化学療法の治療効果判定 膵癌化学療法の治療効果判定 臨床消化器内科 臨床消化器内科 2008 公開
金井 雅史 金井 雅史 がん患者を受け持ったら がん患者を受け持ったら 臨床研修プラクティス 臨床研修プラクティス 2007 公開
金井 雅史 金井 雅史 化学療法中の患者に見られる下痢・便秘 化学療法中の患者に見られる下痢・便秘 medicina medicina 2006 公開

  • <<
  • >>
  • 表示
タイトル言語:
学術賞等
賞の名称(日本語) 賞の名称(英語) 授与組織名(日本語) 授与組織名(英語) 年月
日本学術振興会海外特別研究員 Postdoctoral Fellowship of Japan Society for the Promotion of Science 日本学術振興会 Japan Society for the Promotion of Science 2005
外部資金:競争的資金 (科学研究費補助金)
種別 代表/分担 テーマ(日本語) テーマ(英語) 期間
平成19年度~20年度、若手研究(B) 代表 大腸癌化学療法感受性予測を目指した網羅的なDNA修復酵素の遺伝子多型解析 2007〜2008
平成21年度~22年度、若手研究(B) 代表 オキサリプラチンを用いた大腸癌化学療法の個別化治療を目指した遺伝子多型解析 2009〜2010
基盤研究(C) 代表 網羅的マイクロRNA発現解析を用いたクルクミンの新たな抗腫瘍機序の解明 2012〜2015
厚生労働省科学研究費委託費 分担 膵管内乳頭粘液腫瘍患者における超早期膵癌補足技術の開発 2014/04/01〜
基盤研究(C) 代表 DNA相同組み替え修復遺伝子異常を有する膵癌をターゲットとした個別化医療の開発 (平成29年度分) 2017/04/01〜2018/03/31
基盤研究(C) 代表 DNA相同組み替え修復遺伝子異常を有する膵癌をターゲットとした個別化医療の開発 (平成30年度分) 2018/04/01〜2019/03/31
基盤研究(C) 代表 DNA相同組み替え修復遺伝子異常を有する膵癌をターゲットとした個別化医療の開発 (2019年度分) 2019/04/01〜2020/03/31
担当科目
講義名(日本語) 講義名(英語) 開講期 学部/研究科 年度
疾病概論 Overview of Diseases 前期 医学部(人間健康科学科) 2013/04〜2014/03
臨床内科疾病論Ⅰ Clinical Overview of Internal Medicine I 前期 医学部(人間健康科学科) 2013/04〜2014/03
呼吸循環代謝系病態学 Pathophysiology for Respiration,Circulation and Metabolism 前期 医学部(人間健康科学科) 2013/04〜2014/03
疾病概論 Overview of Diseases 前期 医学部(人間健康科学科) 2014/04〜2015/03
臨床内科疾病論Ⅰ Clinical Overview of Internal Medicine I 前期 医学部(人間健康科学科) 2014/04〜2015/03
呼吸循環代謝系病態学 Pathophysiology for Respiration,Circulation and Metabolism 前期 医学部(人間健康科学科) 2014/04〜2015/03
臨床内科疾病論Ⅰ Clinical Overview of Internal Medicine I 前期 医学部(人間健康科学科) 2015/04〜2016/03
臨床内科疾病論Ⅰ Clinical Overview of Internal Medicine I 前期 医学部(人間健康科学科) 2016/04〜2017/03
臨床内科疾病論Ⅰ Clinical Overview of Internal Medicine I 前期 医学部(人間健康科学科) 2017/04〜2018/03
臨床疾病論B Clinical Overview of Medicine B 後期前半 医学部(人間健康科学科) 2018/04〜2019/03
臨床疾病論B Clinical Overview of Medicine B 後期前半 薬学部 2018/04〜2019/03
臨床疾病論B Clinical Overview of Medicine B 後期前半 医学部(人間健康科学科) 2019/04〜2020/03
臨床疾病論B Clinical Overview of Medicine B 後期前半 薬学部 2019/04〜2020/03
がん看護学特論I Advanced Cancer Nursing Lecture I 前期 医学研究科(人間健康科学系専攻) 2020/04〜2021/03
臨床疾病論B Clinical Overview of Medicine B 後期前半 医学部(人間健康科学科) 2020/04〜2021/03
臨床疾病論B Clinical Overview of Medicine B 後期前半 薬学部 2020/04〜2021/03

  • <<
  • >>
  • 表示
部局運営(役職等)
役職名 期間
動物実験施設運営委員会 2013/04/01〜2019/03/31
海外での滞在歴
滞在機関名 部署 研究テーマ 国名 期間
MD アンダーソンがんセンター Department of Gastrointestinal Medical Oncology 消化器がんの発がんに関与する転写因子の研究 USA 2004/01/01〜2006/03/31
外国人滞在者受入れ
滞在者名 所属機関名 部署 研究テーマ 国名 期間
Xue Peng 上海市第一人民病院 腫瘍科 The mechanism of curcumin potentiates the anti-proliferation effects of gemcitabine in pancreatic cancer 中国 2012/09/01〜2013/08/31